Marquette Asset Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-25,760
| Closed | -$59.8K | – | 257 |
|
2024
Q2 | $59.8K | Hold |
25,760
| – | – | 0.01% | 137 |
|
2024
Q1 | $72.6K | Hold |
25,760
| – | – | 0.01% | 132 |
|
2023
Q4 | $81.9K | Hold |
25,760
| – | – | 0.02% | 124 |
|
2023
Q3 | $85K | Sell |
25,760
-5,328
| -17% | -$17.6K | 0.02% | 117 |
|
2023
Q2 | $103K | Hold |
31,088
| – | – | 0.03% | 117 |
|
2023
Q1 | $103K | Buy |
31,088
+10,068
| +48% | +$33.3K | 0.03% | 107 |
|
2022
Q4 | $75.9K | Buy |
21,020
+7,705
| +58% | +$27.8K | 0.02% | 129 |
|
2022
Q3 | $118K | Hold |
13,315
| – | – | 0.04% | 96 |
|
2022
Q2 | $103K | Hold |
13,315
| – | – | 0.03% | 129 |
|
2022
Q1 | $125K | Hold |
13,315
| – | – | 0.03% | 124 |
|
2021
Q4 | $92K | Buy |
13,315
+81
| +0.6% | +$560 | 0.02% | 157 |
|
2021
Q3 | $126K | Buy |
13,234
+4,315
| +48% | +$41.1K | 0.03% | 129 |
|
2021
Q2 | $89K | Buy |
+8,919
| New | +$89K | 0.02% | 142 |
|